TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 89 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2014. The put-call ratio across all filers is 8.57 and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $28,804,000 | -7.7% | 186,373 | -14.7% | 8.16% | -10.9% |
Q3 2015 | $31,221,000 | +29.9% | 218,500 | +30.6% | 9.15% | +27.6% |
Q2 2015 | $24,038,000 | +1.9% | 167,289 | 0.0% | 7.17% | -17.7% |
Q1 2015 | $23,593,000 | +1.5% | 167,289 | +6.7% | 8.72% | +5.4% |
Q4 2014 | $23,236,000 | – | 156,800 | – | 8.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |